Brain scans could replace costly PET for Alzheimer's drug monitoring
NCT ID NCT07456462
First seen Mar 07, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study aims to find better ways to monitor how well antibody treatments for early Alzheimer's are working. Instead of relying on expensive PET scans, researchers will use advanced MRI and blood tests to build personalized models that predict when a patient's brain has cleared enough harmful protein to safely stop treatment. The goal is to make monitoring safer, cheaper, and more tailored to each person.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD COGNITIVE IMPAIRMENT (MCI) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
San Raffaele Neurology Unit
Milan, Milano, 20132, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.